ANTHONY NJAPA: Open Payments
NPI 1881659019 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 27 payments from 16 companies in 2025. Trend: 2023 $1,011 · 2024 $1,358 · 2025 $614
Food & beverage: $569Education: $45
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 1 | $101 |
| Novo Nordisk Inc | 5 | $89 |
| Lilly USA, LLC | 2 | $66 |
| TOLMAR, INC. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Alkermes, Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Exact Sciences Corporation | 1 | $20 |
| Indivior Inc. | 1 | $20 |
Products named: BRIXADI, Wegovy, JATENZO, REXULTI, VIVITROL, BREZTRI, MOUNJARO, UZEDY.
Industry payments across NC — which companies pay providers there.
